NorthX Biologics
A Swedish development and manufacturing organisation with a focus on advanced biologics, cell and gene therapy, and vaccines.
NorthX has been manufacturing biologics to GMP standards since 1992.
In 2021 NorthX was designated a national innovation hub for advanced therapies and vaccines and has the ambition to become a leading cell and gene therapy manufacturer and partner for innovative drug development companies.
Latest NorthX Biologics News & Features
24 August 2023
25 April 2022
16 October 2021
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze